Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II studyRichard C. Becker, Robert A. Harrington, David J. Moliterno et al.|The Lancet|2009Cited by 298
Effect of Ca <sup>2+</sup> on GP IIb-IIIa Interactions With IntegrilinDavid R. Phillips, Robert M. Scarborough, Lisa K. Jennings et al.|Circulation|1997Cited by 248
Functional relevance of tetraspanin CD9 in vascular smooth muscle cell injury phenotypes: A novel target for the prevention of neointimal hyperplasiaJayaprakash Kotha, Lisa K. Jennings, Chunxiang Zhang et al.|Atherosclerosis|2008Cited by 23
Initiation of rivaroxaban following low molecular weight heparin for thromboprophylaxis after total joint replacement: The Safe, Simple Transitions (SST) studyRoger M. Mills, Peter Wildgoose, Lisa K. Jennings et al.|Thrombosis Research|2012Cited by 12
Initiating thromboprophylaxis with low molecular weight heparin and transitioning to oral rivaroxabanRoger M. Mills, Peter Wildgoose, Richard Berkowitz et al.|European Journal of Hospital Pharmacy|2012Cited by 0